Jean-Pierre Wery

Title: The Innovations of Jean-Pierre Wery

Introduction

Jean-Pierre Wery is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target aspartic proteases. With a total of two patents to his name, Wery's work is paving the way for advancements in medical treatments.

Latest Patents

Wery's latest patents focus on Diaminoalkane aspartic protease inhibitors. These compounds, represented by Formula I, have been discovered to be orally active and capable of binding to aspartic proteases to inhibit their activity. This innovation is particularly useful in treating or ameliorating diseases associated with elevated levels of aspartic protease activity. The invention also encompasses a method for using these compounds in ameliorating or treating aspartic protease-related disorders in subjects in need, by administering an effective amount of a compound of Formula I.

Career Highlights

Jean-Pierre Wery is currently associated with Vitae Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic solutions. His work has garnered attention in the pharmaceutical industry, contributing to advancements in drug development.

Collaborations

Wery collaborates with esteemed colleagues such as John J Baldwin and David A Claremon, enhancing the research and development efforts at Vitae Pharmaceuticals, Inc. Their combined expertise fosters a productive environment for innovation.

Conclusion

Jean-Pierre Wery's contributions to the field of pharmaceuticals through his patents on Diaminoalkane aspartic protease inhibitors highlight his role as a significant inventor. His ongoing work promises to impact the treatment of diseases related to aspartic protease activity positively.